🇺🇸 FDA
Patent

US 10195291

Compositions and methods for the manufacture of lipid nanoparticles

granted A61KA61K31/713A61K47/10

Quick answer

US patent 10195291 (Compositions and methods for the manufacture of lipid nanoparticles) held by Alnylam Pharmaceuticals, Inc. expires Mon Jan 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Alnylam Pharmaceuticals, Inc.
Grant date
Tue Feb 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/713, A61K47/10, A61K47/12, A61K47/14